ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Eating Behaviours of Patients with Initial Presentation of Parkinson’s Disease

DOI:10.31550/1727-2378-2018-153-9-36-39
Bibliography link: Bogdanov А.R., Bogdanov R.R., Matyuk Yu.V. Eating Behaviours of Patients with Initial Presentation of Parkinson's Disease. Doctor.Ru. 2018; 9(153): 36–39. DOI: 10.31550/1727-2378-2018-153-9-36-39
9 November 10:10

Study Objective: to analyse the eating behaviours of patients with initial presentation of Parkinson’s disease (PD).

Study Design: cohort cross-sectional study.

Materials and Methods. 65 patients with initial PD were examined (disease stage I-II (Hoehn and Yahr Rating Scale). The eating behaviour was analysed using Nutrilogic software developed by the Federal Research Centre of Nutrition, Biotechnology and Food Safety.

Study Results. Patients demonstrated excessive fat consumption (+37.6%), mostly due to saturated fats (+36.4%), accompanied by deficit of polyunsaturated fatty acids, primarily of omega-3 group (-45.0%). Excessive consumption of simple carbohydrates (+32.5%) and food fibre deficit (-61.0%) were noted. Besides, it was found out that subjects suffered from vitamin deficit, primarily of vitamin А (-56.3%), magnesium (-9.2%), and excessive ferrum (+22.0%) and calcium (+6.4%) consumption.

Conclusion. Analysis of eating behaviours of patients with initial presentation of PD demonstrated deviations from individual physiological needs requiring nutritional correction followed up by assessment of its efficiency in order to improve the quality of life of patients with PD.

А.R. Bogdanov — Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow. N.I. Pirogov Russian National Research Medical University of the Ministry of Public Health of Russia, Moscow. E-mail: bogdanov.ar@mail.ru

R.R. Bogdanov — M.F. Vladimirskiy Moscow Regional Scientific and Research Clinical Institute. E-mail: moniki-nevrol@mail.ru

Yu.V. Matyuk — M.F. Vladimirskiy Moscow Regional Scientific and Research Clinical Institute. E-mail: myst19@mail.ru

Доктор.ру
9 November 10:10
LITERATURE
  1. Kasten M., Chade A., Tanner C.M. Epidemiology of Parkinson's disease. Handb. Clin. Neurol. 2007; 83: 129–51. DOI: 10.1016/S0072-9752(07)83006-5
  2. Brooks D.J. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J. Neurol. 2000; 247(Suppl. 2): II11–8
  3. Пилипович А.А. Немоторные симптомы болезни Паркинсона. Consilium Medicum. Неврология и ревматология. 2014; 2: 29–33. [Pilipovich A.A. Nemotornye simptomy bolezni Parkinsona. Consilium Medicum. Nevrologiya i revmatologiya. 2014; 2: 29–33. (in Russian)]
  4. Sjödahl Hammarlund C., Hagell P., Nilsson M.H. Motor and non-motor predictors of illness-related distress in Parkinson's disease. Parkinsonism Relat. Disord. 2012; 18(3): 299–302. DOI: 10.1016/j.parkreldis.2011.10.015
  5. Martínez-Martín P., Rodríguez-Blázquez C., Forjaz M.J., Alvarez-Sánchez M., Arakaki T., Bergareche-Yarza A. et al. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. Eur. J. Neurol. 2014; 21(3): 519–24. DOI: 10.1111/ene.12349
  6. Титова Н.В., Чаудури K.Р. Немоторные симптомы болезни Паркинсона: подводная часть айсберга. Анналы клин. и эксперим. неврологии. 2017; 11(4): 5–18. [Titova N.V., Chauduri K.R. Nemotornye simptomy bolezni Parkinsona: podvodnaya chast' aisberga. Annaly klin. i eksperim. nevrologii. 2017; 11(4): 5–18. (in Russian)]
  7. Богданов Р.Р., Мананникова Е.И., Котов С.В., Богданов А.Р. Особенности немоторных проявлений на ранних стадиях болезни Паркинсона. Доктор.Ру. 2013; 5(83): 24–8. [Bogda­nov R.R., Manannikova E.I., Kotov S.V., Bogdanov A.R. Osobennosti nemotornykh proyavlenii na rannikh stadiyakh bolezni Parkinsona. Doktor.Ru. 2013; 5(83): 24–8. (in Russian)]
  8. Fereshtehnejad S.M., Ghazi L., Shafieesabet M., Shahidi G.A., Delbari A., Lökk J. Motor, psychiatric and fatigue features associated with nutritional status and its effects on quality of life in Parkinson's disease patients. PLoS One. 2014; 9(3): e91153. DOI: 10.1371/journal.pone.0091153
  9. Barichella M., Cereda E., Madio C., Iorio L., Pusani C., Cancello R. et al. Nutritional risk and gastrointestinal dysautonomia symp­toms in Parkinson's disease outpatients hospitalised on a schedu­led basis. Br. J. Nutr. 2013; 110(2): 347–53. DOI: 10.1017/S0007114512004941
  10. Benarroch E.E. Neural control of feeding behavior: Overview and clinical correlations. Neurology. 2010; 74(20): 1643–50. DOI: 10.1212/WNL.0b013e3181df0a3f
  11. Barichella M., Cereda E., Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov. Disord. 2009; 24(13): 1881–92. DOI: 10.1002/mds.22705
  12. Wang Y.L., Wang Y.T., Li J.F., Zhang Y.Z., Yin H.L., Han B. Body mass index and risk of Parkinson's disease: a dose-response meta-analysis of prospective studies. PLoS One. 2015; 10(6): e0131778. DOI: 10.1371/journal.pone.0131778
  13. Chen H., Zhang S.M., Schwarzschild M.A., Hernán M.A., Willett W.C., Ascherio A. Obesity and the risk of Parkinson's disease. Am. J. Epidemiol. 2004; 159(6): 547–55
  14. De Pablo-Fernández E., Breen D.P., Bouloux P.M., Barker R.A., Foltynie T., Warner T.T. Neuroendocrine abnormalities in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 2017; 88(2): 176–85. DOI: 10.1136/jnnp-2016-314601
  15. Kashihara K. Weight loss in Parkinson's disease. J. Neurol. 2006; 253 (Suppl. 7): VII38–41
  16. Wise R.A. Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol. Psychiatry. 2013; 73(9): 819–26. DOI: 10.1016/j.biopsych.2012.09.001
  17. Cumming K., Macleod A.D., Myint P.K., Counsell C.E. Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study. Neurology. 2017; 89(22): 2254–61. DOI: 10.1212/WNL.0000000000004691
  18. Sharma J.C., Vassallo M. Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. Neurodegener. Dis. Manag. 2014; 4(4): 309–16. DOI: 10.2217/nmt.14.25
  19. Luong K.V., Nguyễn L.T. The beneficial role of thiamine in Parkinson disease. CNS Neurosci. Ther. 2013; 19(7): 461–8. DOI: 10.1111/cns.12078
  20. Miyake Y., Fukushima W., Tanaka K., Sasaki S., Kiyohara C., Tsuboi Y. et al.; Fukuoka Kinki Parkinson's Disease Study Group. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur. J. Neurol. 2011; 18(1): 106–13. DOI: 10.1111/j.1468-1331.2010.03088.x
  21. Costa-Mallen P., Gatenby C., Friend S., Maravilla K.R., Hu S.C., Cain K.C. et al. Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease. J. Neurol. Sci. 2017; 378: 38–44. DOI: 10.1016/j.jns.2017.04.035
  22. Cheng P., Yu J., Huang W., Bai S., Zhu X., Qi Z. et al. Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis. Neurol. Sci. 2015; 36(12): 2269–75. DOI: 10.1007/s10072-015-2349-0
  23. Yang F., Wolk A., Håkansson N., Pedersen N.L., Wirdefeldt K. Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts. Mov. Disord. 2017; 32(11): 1631–6. DOI: 10.1002/mds.27120
  24. Gao X., Cassidy A., Schwarzschild M.A., Rimm E.B., Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012; 78(15): 1138–45. DOI: 10.1212/WNL.0b013e31824f7fc4
  25. Mischley L.K., Lau R.C., Bennett R.D. Role of diet and nutritional supplements in Parkinson’s disease progression. Oxid. Med. Cell. Longev. Vol. 2017. Art. ID 6405278. 9 p. URL: https://doi.org/10.1155/2017/6405278 (дата обращения — 20.09.2018)
  26. Богданов Р.Р., Богданов А.Р., Котов С.В. Тактика ведения пациентов с начальными проявлениями болезни Паркинсона. Доктор.Ру. 2012; 5(73): 17–21. [Bogdanov R.R., Bogdanov A.R., Kotov S.V. Taktika vedeniya patsientov s nachal'nymi proyavleniyami bolezni Parkinsona. Doktor.Ru. 2012; 5(73): 17–21. (in Russian)]
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)

News